Arterial Revascularization Trial (ART): What does it mean?
Dr. Faisal Bakaeen, Director of Cleveland Clinic's Coronary Artery Bypass Surgery Center discusses the findings of the ART trial, which showed no difference in the composite end point of death, myocardial infarction or stroke between the BITA (bilateral internal thoracic artery) and SITA (single internal thoracic artery) for coronary artery bypass graft surgery. He provides an explanation of the findings and encourages tailoring the surgery to the patient. Use of multi-arterial coronary artery bypass grafts for the right patient can provide the best long term outcomes. Learn more about this topic on ConsultQD.